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Introduction {#sec001}
============

Phytogenic additives are encountering growing interest in poultry nutrition due to their potential beneficial influence on lipid metabolism, useful gut microflora, nutrient absorption, performance, health and welfare \[[@pone.0216623.ref001]--[@pone.0216623.ref003]\]. In particular, dietary supplementation with thymol (THY; 2 isopropyl-5-methylphenol) or mixtures that contain THY, has been proposed as strategy to enhance poultry productivity in parameters such as growth, feed conversion, egg laying rate and egg physico-chemical quality \[[@pone.0216623.ref004]--[@pone.0216623.ref007]\]. Additionally, THY potential for modulating the fatty acid (FA) profile and preventing lipid peroxidation in certain tissues of a variety of species \[[@pone.0216623.ref008]--[@pone.0216623.ref010]\] has promoted research aimed at improving nutritional quality of meat \[[@pone.0216623.ref011]--[@pone.0216623.ref013]\] and egg products \[[@pone.0216623.ref014]--[@pone.0216623.ref016]\]. From a human nutritional standpoint, consuming products with higher levels of n-3 polyunsaturated FA (n-3 PUFA) and lower saturated FA (SFA) is associated with a number of physiological and health-beneficial effects, such as prevention of some chronic diseases \[[@pone.0216623.ref017],[@pone.0216623.ref018]\]. Also, in the context of early avian nutrition, adequate amounts of PUFA in the yolk are essential to meet the demands of the developing embryo \[[@pone.0216623.ref019],[@pone.0216623.ref020]\]. Modulation of the FA profile by diverse dietary supplements containing THY has been largely attributed to THY antioxidant activity via scavenging of free radicals, enhancing the bird's endogenous enzymatic and non-enzymatic antioxidants, chelating of metal ions and regulation of different signaling pathways \[[@pone.0216623.ref005],[@pone.0216623.ref006]\].

As a bioactive compound, THY has potential for physiological effects at various levels \[[@pone.0216623.ref021]\]. *In vitro* results in different cell lines and experimental systems showed that THY promotes dose-response effects (reviewed in \[[@pone.0216623.ref006]\]). However, *in vivo* studies in poultry, reflect inconsistencies in relation to dose-response effects, which can be explained, in part, by substantial differences in supplementation protocols used \[[@pone.0216623.ref004],[@pone.0216623.ref013],[@pone.0216623.ref022]--[@pone.0216623.ref026]\]. In particular, there are fundamental differences regarding presentation form of the supplement (ranging from herbs to commercial mixtures with several EO), doses administered (\<mg to g/kg feed), duration of supplementation (days to months) and age of animals supplemented (chicks to adults), which could ultimately impact, among other aspects, on bioavailability or amount of the supplement that can be absorbed, used and/or stored by the animal \[[@pone.0216623.ref021],[@pone.0216623.ref027],[@pone.0216623.ref028]\]. Although the contributions of these studies are of great importance, the wide range of supplementation protocols hinders an adequate understanding of the scope of THY effects, as well as the characteristics of its *in vivo* mode of action, thus, making it difficult to identify supplementation aspects (e.g. absorption, target tissues, etc.) that are important in order to promote accurate nutritional recommendations. This background highlights the need for studies using pure THY (as a single compound), at various doses throughout the supplementation protocol, to determine whether there are doses or durations of supplementation thresholds capable of promoting biologically relevant responses.

In species such as rabbits, pigs, rodents and humans there is a fairly good number of studies on THY absorption, digestion, metabolism, excretion and bioavailability, which provide valuable background information in the context of the nutrition of monogastric animals in general. However, these studies have been conducted in acute administration and provided short-term data regarding the permanence of these compounds and/or their derivatives in the animal body \[[@pone.0216623.ref029]--[@pone.0216623.ref033]\]. On the contrary, as stated previously, application protocols proposed in animal nutrition involve chronic supplementation of these compounds. In this regard, few studies in poultry evaluated the bioavailability or concentration of supplemented compounds in target tissues. The scarceness of this information has been attributed partially to methodological difficulties. Recently, methodologies based on HS-SPME coupled to GC-MS and SPE coupled to UHPLC-QTOF-MS have been developed, enabling these determinations \[[@pone.0216623.ref034]--[@pone.0216623.ref037]\]. Of special interest for us are the results in broiler chickens \[[@pone.0216623.ref034]\] demonstrating that THY from thyme herb (consisting of leaves and flowers without stems) at 0, 1, 2, 3 and 10 g/kg of feed is efficiently absorbed, distributed to various tissues and excreted after a supplementation trial of 35 days. They also observed an increased intestinal THY concentrations in the group with 10g/kg feed compared to the other groups. Likewise, it has been demonstrated that THY concentration in the egg yolk reached a plateau after 12 days of dietary supplementation, in laying hens fed with thyme extracts at doses equivalent to 2.24 and 3.36 g of THY/kg feed \[[@pone.0216623.ref038]\]. Additionally, they observed that once supplementation was withdrawn, THY concentration of the yolk decreased gradually. However, these studies, as mentioned above, not only use supplements that are mixtures of different compounds, but also they lack a joint assessment of the dynamics of changes in bioavailability and biological effects (i.e., feed intake, body weight, egg physico-chemical characteristics, etc.) potentially promoted during supplementation (S) or in the post-supplementation (pS) period. This approach is key to understand how supplemented compounds modulate beneficial effects on animal body, thus contributing to determine to what extent the biological effects depend on the circulating levels and/or the concentration of the active compounds in target tissues \[[@pone.0216623.ref021],[@pone.0216623.ref028]\]. Measuring bioavailability may also be relevant in context of the safety of edible animal by-products (i.e., eggs and meat).

Although THY has the 'generally recognized as safe' (GRAS) status of US government-approved food additives, with safety levels calculated in a wide range of animal species by the European Food Safety Authority \[[@pone.0216623.ref039]\], further studies complementing toxicological and persistence effects after chronic supplementation *in vivo* are still needed. Moreover, recent reviews have also call for the need of detailed assessment of toxic effects on liver, due to its role in phenolic compounds\' metabolism, as xenobiotic biotransformer and in circulatory system \[[@pone.0216623.ref005]\].

Thus, we studied the link between the dynamics of free THY concentration and the changes in FA composition in quail egg yolk, both during a month-long chronic dietary supplementation and after 3 weeks of supplement withdrawal. To evaluate whether the observed effects are dose dependent, 3 increasing doses of THY (2, 4, and 6.25 g of THY/kg of feed) were evaluated. In parallel, we assessed the concomitant changes in free THY excretion as a non-invasive indicator of the presence of THY in circulation. We also monitored potential liver histopathological changes due to toxicity, as well as female performance traits.

Materials and methods {#sec002}
=====================

Ethical statement {#sec003}
-----------------

All experimental procedures were in compliance with the *Guide for the Care and Use of Laboratory Animals* issued by the National Institute of Health \[[@pone.0216623.ref040]\]. The experimental protocol was approved by the Institutional Committee for the Care and Use of Laboratory Animals (Comité Institucional para el Cuidado y Uso de Animales de Laboratorio (CICUAL) of the Facultad de Ciencias Exactas, Físicas y Naturales, Universidad Nacional de Córdoba (ACTA 4/2015 Resolución 571-HCD-2014). The raw data of all variables presented herein is publicly available on figshare, doi: [10.6084/m9.figshare.7589066](https://doi.org/10.6084/m9.figshare.7589066).

Animals and husbandry {#sec004}
---------------------

Adult female Japanese quail (*Coturnix japonica*) taken from a population of a single 230-bird, hatched in our laboratory, were used in this study. Husbandry was performed according to laboratory routines described elsewhere \[[@pone.0216623.ref016],[@pone.0216623.ref041]\]. Briefly, at 28 days of age, females were individually housed in cages measuring 20cm × 45cm × 25cm (length × width × height), allowing them to establish visual and auditory contact with each other, while permitting individual measurements of feed consumption and egg production. An individual feeder and an automatic nipple drinker were positioned in each cage. At all stages feed and water were provided *ad libitum*. The photoperiod was 14h light and 10h dark (0600--2000h; approximately 300--320 lx). The environmental temperature was maintained at 24 ± 2°C.

General procedure {#sec005}
-----------------

A total of 50 eighty-five days-old female quail of homogeneous body weights (251 ± 1 g; Mean ± SE) and in their egg-laying peak were selected from an initial group of 96 female individuals. All birds continued receiving a basal diet between 85 and 100 days of age and all variables (see below for details) were registered along this period (Pre-supplementation period, [Fig 1](#pone.0216623.g001){ref-type="fig"}). From 100 to 128 days of age (S period, [Fig 1](#pone.0216623.g001){ref-type="fig"}), females were randomly assigned to either a chronic dietary supplementation with one of 3 THY doses (THY2, THY4 and THY6; 10 females each) or to one of 2 control groups (basal diet, BASAL, and basal diet with vehicle solution, VEHICLE; 10 females each). Once finished the S period, half of the quail were slaughtered for histological analysis (n = 25; Slaughter 1, [Fig 1](#pone.0216623.g001){ref-type="fig"}) and the other half were subjected to a pS period of 21 days, during which all females received the BASAL diet (pS, [Fig 1](#pone.0216623.g001){ref-type="fig"}). After this period, the remaining 25 animals were also slaughtered for histological analysis (Slaughter 2, [Fig 1](#pone.0216623.g001){ref-type="fig"}). In this way, we assessed whether THY induced changes in variables indicative of tissue damage and if so, whether the potential damages could reverse after 3 weeks of supplement withdrawal.

![Timeline scheme.\
The age of the birds (days) is indicated on the horizontal axis. All birds received the basal diet between 85 and 100 days of age. From 100 to 128 days of age, females were subjected to chronic dietary supplementation (S). Five diets (N = 50; n = 10) were administrated (indicated with boxes): two controls (BASAL and VEHICLE) and three increasing doses of THY (THY2, THY4 and THY6, corresponding to 2, 4 and 6.25 g of THY/kg feed, respectively). Vertical dotted lines indicate changes in the diet of each experimental group. Once finished the supplementation period, half of the quail were slaughtered for histological analysis (Slaughter 1). The other half of the quail was subjected to a post-supplementation period of 21 days (pS) during which the basal diet was reestablished. Finished de pS period, the remaining birds were slaughtered (Slaughter 2). To assess dynamics five sample points were defined: one initial sample point; three sample points along the S period and one at the end of the pS period.](pone.0216623.g001){#pone.0216623.g001}

To assess changes in egg yolk total FA composition, egg physical characteristics, laying rate, body weight, feed intake and general welfare, during the S and pS periods, five sampling points were defined (Sample points, [Fig 1](#pone.0216623.g001){ref-type="fig"}): one initial sample point (at 0 days of S); three sample points during the S period (at 7, 14 and 28 days of S); and one sample point at the end of the pS period (21 days of pS). It should be noted that for determinations of THY concentration, eggs and quail droppings were collected offset from the other variables measured by 2 days, thus were collected on days 2, 9, 16, and 26 days of S, and 17 days of pS, respectively.

Thus, a bi-factorial design combining the effects of the diet supplied (five levels) and time of sampling (five levels) was established for the variables studied.

Dietary supplementation {#sec006}
-----------------------

Thymol was commercially obtained from Sigma-Aldrich (SAFC®, ⩾99%; FCC, Saint Louis, MO, USA). Supplemented quail were provided 2, 4 or 6.25 g of THY per kg of feed. For this end, THY was prepared in a 2.4, 4.8 and 7.5% w/v ethanolic solution and uniformly sprayed on fresh feed \[[@pone.0216623.ref016]\]. The feed was prepared and administrated daily, to minimize THY volatilization from feed before its consumption by females. The doses were selected considering two factors. The first, the concentration range for which the transfer of THY to the chicken and/or quail egg has been established \[[@pone.0216623.ref037],[@pone.0216623.ref038]\]. Second, the concentrations of THY supplementation that have shown biological effects. For example, it was shown that THY2 reduces female quail fear responses when birds are exposed to stressful situations without affecting the bird´s locomotor activity \[[@pone.0216623.ref041]\]; and that THY6 enhances PUFA deposition to the detriment of SFA in yolk total fatty acids and triglycerides of the quail fertile egg \[[@pone.0216623.ref016]\]. In this context, THY4 is and intermediate dose between the last two. Nutrient and FA compositions of the diets supplied were identical between each other and are reported in [S1](#pone.0216623.s001){ref-type="supplementary-material"}, [S2](#pone.0216623.s002){ref-type="supplementary-material"} and [S3](#pone.0216623.s003){ref-type="supplementary-material"} Tables, and are in accordance with the National Research Council recommendation \[[@pone.0216623.ref042]\].

Thymol quantification in egg yolk, quail droppings and feed {#sec007}
-----------------------------------------------------------

Egg yolks and droppings of each female were obtained at each sample point (Sample points, [Fig 1](#pone.0216623.g001){ref-type="fig"}) and THY concentration was immediately measured by head space-solid phase microextraction followed by gas chromatography-mass spectrometry (HS-SPME/GC-MS) according to Fernandez et al. \[[@pone.0216623.ref037]\]. SPME was performed with a manual holder with 100 um polydimethylsiloxane (PDMS) fiber. An aliquot of egg yolk (3 g), droppings (5 g) or feed (5 g) was put in a sealed 20 mL glass vial, spiked at the corresponding level with the standard m-cresol (Sigma-Aldrich; ≥ 99% (GC); Saint Louis, MO, USA) stock solution, and vortexed for 5 min. The vials were placed in a water bath and the PDMS fiber was exposed to the headspace for 30 min at 60°C and 5 min at 40°C for egg yolk and droppings or feed, respectively. The fiber was then inserted directly into the GC injector for desorption at 250°C for 10 min in splitless mode. Chromatography analysis was carried out in a Perkin Elmer Clarus 600 equipped with a PSSI injector and a quadrupole MS detector (Perkin Elmer, USA). Turbo Mass 5.4.2 software was used to control and acquire data from GC--MS. All the separations were performed using a Perkin Elmer fused silica DB 5 MS capillary column (60 m, 0.25 mm ID, 0.25 um film thickness), with High-purity helium (99.998%) as a carrier gas (49.6 psi). The splitless injection mode was selected. Electron-impact Ionization was carried out in the mass spectrometer under vacuum with 70-eV ionization energy. Samples were analyzed under the following chromatographic and MS detection conditions: initial oven temperature was set at 100°C (held for 2 min), and then raised to 230 at 10°C/min rate. A column head pressure of 14.99 psi and an injector temperature of 280°C were set. The GC transfer line was maintained at 250°C. The fiber was desorbed in the GC injector port for 10 min. Chromatograms were acquired in scan mode, which scans the quadrupole from m/z = 50 to m/z = 300 (scan time: 0.20 s, inter-scan time: 0.10 s). All quantitative analyses were performed in TIC mode. The compounds were identified by comparing their mass spectra with those of the libraries of the NIST MS search 2.0. The main components were further identified by co-injection of commercial standards.

Total fatty acid analysis in egg yolks {#sec008}
--------------------------------------

Eggs were obtained at each sample point (Sample points, [Fig 1](#pone.0216623.g001){ref-type="fig"}) and stored at -20°C until yolk total fatty acids analysis. Lipids were extracted from the yolk following homogenization in a suitable excess of chloroform/methanol (2:1 v/v) \[[@pone.0216623.ref043]\]. The solvents were removed under reduced pressure in a rotary evaporator. Lipids were subjected to alkaline saponification (1 mol/L potassium hydroxide in methanol), and the unsaponifiable matter was extracted with *n*-hexane. The fatty acid methyl esters (FAMEs) were prepared by transmethylation through treatment with 1 mol/L sulfuric acid in methanol and analyzed by gas chromatography/mass spectrometry (GC/MS) \[[@pone.0216623.ref016],[@pone.0216623.ref044]\]. All chemicals used in this study were reagent-grade commercial products. FAMEs were analyzed by gas chromatography on a 60 m fused capillary column with an internal diameter of 0.25 mm (PerkinElmer Elite-WAX Polyethylene Glycol). The analysis was performed on a PerkinElmer Clarus® 600 GC/MS system equipped with a flame ionization detector (Waltham, MA, USA). Helium was used as carrier gas (constant flow of 49.6 psi). The injection port temperature was 250°C and the detector temperature was 250°C. The oven temperature was initially held at 180°C for 5 min, then increased at 4°C/min to 200°C and held for 5 min and finally increased at 3°C/min to 230°C and held for 25 min. Peak identification was carried out by comparing the known retention times for the fatty acids reported with the temperature program and the chromatographic system used. A solution of known concentration of nonadecanoic acid methyl ester (Sigma Aldrich, ≥98.0% (GC); Saint Louis, MO, USA) as was used internal standard to estimate the content of each fatty acid in the sample.

Female performance traits {#sec009}
-------------------------

Female performance was evaluated through the measurement of body weight, feed intake, egg laying rate, egg physical characteristics and a general welfare quality assessment. Body weight was measured once a week throughout the experimental period. Daily feed intake (DFI) was estimated as the difference between the amount of feed supplied to each animal (60 g) and the rest that remained in the feeders the next day (g of feed/day/quail) \[[@pone.0216623.ref045],[@pone.0216623.ref046]\]. Egg laying was registered daily and the weekly laying rate was calculated as: (number of eggs / 7 days) x 100. Egg weight, quality characteristics (such as intact, membranous, soft shell and broken shell), morphometric characteristics (egg shape index = (egg width / egg length) x 100) and percentage of constituents (egg yolk, albumen and shell) were registered at each sampling point \[[@pone.0216623.ref015],[@pone.0216623.ref047]\].

A welfare assessment based on observations of physical characteristics was made. Female skin lesions and plumage status were evaluated following a procedure proposed by Pellegrini et al. \[[@pone.0216623.ref048]\] that is an adapted version of the protocol developed by the Welfare Quality consortium \[[@pone.0216623.ref049]\]. Briefly, skin lesions, which include wounds that have not healed in the legs, rear end, chest, cloacae and wings were determined using a score scale from 0 to 2, where \"0\" represents no lesions or scratches, \"1\" represents at least one lesion \< 0.5 cm diameter or less than 3 pecks (punctiform damage \~ 0.1 cm of diameter) or scratches, and \"2\" reflects one lesion ≥ 0.5 cm of diameter or more than 3 pecks or scratches. Plumage damage was also determined using a score scale from 0 to 2 as follows: \"0\" represents individuals with no plumage damage or slight wear (only single feathers lacking), \"1\" represent individuals with one or more body parts that have moderate wear (i.e. damaged feathers worn or deformed) or one or more featherless areas \< 1.5 cm in diameter at the larger extent and \"2\" corresponded to individuals that have at least one featherless area \> 1.5 cm in diameter at the largest extent. Foot pad dermatitis, for which both feet were analyzed and the foot with the worst condition was scored according to the following: \"0\" representing feet intact, no or minimal proliferation of epithelium, \"1\" corresponded to necrosis or proliferation of epithelium or chronic bumble foot with no or moderate swelling, and \"2\" indicated swollen dorsally visible. Eye pathologies, which include swelling of the eyelids and the skin around the eyes, closure of the eye/eyes and discharge from the eyes were classified as \"0\" when no evidence of eye pathologies were observed or \"1\" if a there were eye pathologies. Additionally, dirt from the legs, cloacae and belly was examined for signs of diarrhea potentially caused by dietary supplementation.

Liver histological analysis {#sec010}
---------------------------

At each slaughter point birds were euthanized by decapitation and livers were removed and stored in buffered formalin at 10%, processed routinely and stained with hematoxylin and eosin (H&E) and periodic acid-Schiff (PAS). Each slide was examined blinded, with a light microscope (Olympus X-785) and photographed with a digital camera (Moticam Camera 2300, 3 Megapixels). To evaluate histological alterations of liver, tissue was divided into 8 random equal areas to ensure there was no overlapping of the studied areas. For each area, the extension and number of each alteration were recorded with a microscope at 40X magnitude. Histopathological index of liver (HI~liv~) were estimated using a semi-quantitative protocol following \[[@pone.0216623.ref050]\], modified by our colleagues \[[@pone.0216623.ref051]\]. Briefly, alterations were classified into four major reaction patterns each one of those including alterations that concern to different functional units of the liver or to the whole organ: RP1, circulatory disturbances (dilatation of sinusoids, vascular congestion, hemorrhage); RP2, regressive changes (steatosis or fatty degeneration, hydropic degeneration, nuclear alteration, fibrosis, necrosis); RP3, progressive changes (oval cells, cell hypertrophy and hyperplasia); and RP4, liver inflammation (leukocyte infiltration). Then, for each RP, an index was calculated based on two factors: the pathological importance of the lesions (importance factor, W) (range 1--3) and the extension of pathological change (score value, a) from 0 (unchanged) to 8 (extreme occurrence). Finally, a total liver histopathological index (HI~liv~) was calculated by adding the single RP liver indices of each individual quail. A greater value of (HI~liv~) reflects the most severely affected individual.

Statistical analysis {#sec011}
--------------------

General and generalized linear mixed models were used in order to analyze the effects of the diet supplied (5 levels of factor) and time of sampling (5 levels of factor) throughout experimental manipulation. The diet supplied and time of sampling were included as fixed effects and female identity was included as a random effect for THY concentration, FA composition, feed intake, body weight, morphometric variables and percentage of egg constituents. For histological analysis, a two-way ANOVA including the diet supplied and the slaughter batch (28 days of S or 21 days of pS) as effects was used. Egg-laying was analyzed as cumulative number of eggs using a one-way ANOVA with the diet supplied as unique factor. Data were analyzed according to normal distribution unless stated otherwise and assumptions of the tests were verified. The variables THY concentration, weekly body weight, SFA, arachidonic, eicosapentaenoic and docosapentaenoic acids of egg yolk were transformed before analysis (log10 was used for THY concentration in the yolk and weekly body weight, root square for THY concentration in the droppings, and Logit for all other variables). Palmitic and stearic acids and egg weight that were analyzed according to gamma distribution. A P-value of \<0.05 was considered to represent significant differences. DGC test was used for post hoc comparisons. All statistical analyses were performed with 'R' (The R Foundation for Statistical Computing) through a user-friendly interface implemented in InfoStat \[[@pone.0216623.ref052]\].

Results {#sec012}
=======

Thymol quantification in egg yolks and droppings {#sec013}
------------------------------------------------

The dose-dependent effects of the diet supplied over the time of sampling on THY concentration in the egg yolk and droppings are shown in [Fig 2](#pone.0216623.g002){ref-type="fig"}. In the egg yolk, significant effects ([Table 1](#pone.0216623.t001){ref-type="table"} and [Fig 2A](#pone.0216623.g002){ref-type="fig"}) of both the diet supplied and time of sampling on THY concentration were found. Post-hoc analysis showed that THY concentration increased on 9 days of S. Subsequently, the concentration reached a plateau that lasted until the end of the S period. After supplement withdrawal, THY concentration decreased. Regarding the THY doses tested, it was found that the higher the dose supplemented, the higher the concentration it is detected. In dropping samples, a significant interaction ([Table 1](#pone.0216623.t001){ref-type="table"} and [Fig 2B](#pone.0216623.g002){ref-type="fig"}) between the diet supplied and time of sampling was observed, with the same general pattern described in the egg yolk with the exception that THY6 was higher than THY4 only at 16 and 26 days of S and that THY2 was higher at 26 days than at 16 days of S.

![Thymol concentration in quail egg yolk and droppings.\
Mean ± SEM of thymol concentration (ng/g) in the (A) egg yolk and (B) droppings from females fed on diets with 2, 4, and 6.25 g of thymol/kg of feed (THY2, THY4 and THY6, respectively) at 2, 9, 16, and 26 days of the supplementation period (S) and after 17 days of supplement withdrawal (pS). Arrow pointing down indicates the end of the S period. In Fig 2A different letters (a, b, c) and numbers (1, 2, 3) indicate statistical differences for the diet supplied and time of sampling, respectively. In Fig 2B different letters (a, b, c, d, e, f) indicate statistical differences for the interaction. The same 15 females (5 per THY supplemented diet) were sampled on each of the five sample points (75 eggs and 45 droppings samples total). BASAL and VEHICLE samples were evaluated at the beginning and end of the day at each sample point to assure the absence of THY.](pone.0216623.g002){#pone.0216623.g002}

10.1371/journal.pone.0216623.t001

###### Statistical information corresponding to the effects of the diet supplied, time of sampling and their interaction on thymol (THY) concentration in quail egg yolk and droppings and concentration of egg yolk total fatty acids.

![](pone.0216623.t001){#pone.0216623.t001g}

  ---------------------------------------------------------------------------------------------------------------------------------------------------------
  Variables                             N; n             Analysis of variance factors and degrees of freedom                         
  ------------------------------------ -------- -------- ----------------------------------------------------- --------------------- ----------------------
  THY concentration in the egg yolk    75;5     F        160.86 (dF = 2;12)                                    505.77 (dF = 4; 48)   1.91 (dF = 8; 48)

  P                                    0.0001   0.0001   0.0805                                                                      

  THY concentration in the droppings   45;3     F        84.99 (dF = 2; 6)                                     314.08 (dF = 4; 24)   5.12 (dF = 8; 24)

  P                                    0.0001   0.0001   0.0008                                                                      

  Saturated Fatty Acids (SFA)          125; 5   F        20.22 (dF = 4;20)                                     24.07 (dF = 4; 80)    7.57 (dF = 16; 80)

  P                                    0.0001   0.0001   0.0001                                                                      

  Monounsaturated Fatty Acids (MUFA)   125; 5   F        0.61 (dF = 4;20)                                      1.03 (dF = 4; 80)     0.45 (dF = 16; 80)

  P                                    0.67     0.4      0.96                                                                        

  Polyunsaturated Fatty Acids (PUFA)   125; 5   F        18.27 (dF = 4; 20)                                    10.27 (dF = 4; 80)    4.40 (dF = 16; 80)

  P                                    0.0001   0.0001   0.0001                                                                      

  Palmitic acid (16:0)                 125; 5   χ^2^     15.90 (dF = 4; 20)                                    34.19 (dF = 4; 80)    89.58 (dF = 16; 80)

  P                                    0.003    0.0001   0.0001                                                                      

  Stearic acid (18:0)                  125; 5   χ^2^     16.14 (dF = 4; 20)                                    27.51 (dF = 4; 80)    45.55 (dF = 16; 80)

  P                                    0.003    0.0001   0.0001                                                                      

  Palmitoleic acid (16:1)              125; 5   F        3.23 (dF = 4; 20)                                     1.46 (dF = 4; 80)     3.28 (dF = 16; 80)

  P                                    0.03     0.22     0.0002                                                                      

  Oleic acid (18:1)                    125; 5   F        1.08 (dF = 4; 20)                                     0.73 (dF = 4; 80)     0.47 (dF = 16; 80)

  P                                    0.4      0.58     0.96                                                                        

  Linoleic acid (18:2)                 125; 5   F        0.90 (dF = 4; 20)                                     0.61 (dF = 4; 80)     1.03 (dF = 16; 80)

  P                                    0.48     0.66     0.44                                                                        

  Linolenic acid (18:3)                125; 5   F        1657.30 (dF = 4; 20)                                  716.39 (dF = 4; 80)   306.90 (dF = 16; 80)

  P                                    0.0001   0.0001   0.0001                                                                      

  Arachidonic acid (20:4)              125; 5   F        33.86 (dF = 4; 20)                                    8.93 (dF = 4; 80)     5.53 (dF = 16; 80)

  P                                    0.0001   0.0001   0.0001                                                                      

  Docosahexaenoic acid\                125; 5   F        92.43 (dF = 4; 20)                                    49.46 (dF = 4; 80)    14.09 (dF = 16; 80)
  (22:6)                                                                                                                             

  P                                    0.0001   0.0001   0.0001                                                                      

  Eicosapentaenoic acid\               125; 5   F        9.16 (dF = 4; 20)                                     12.34 (dF = 4; 80)    3.67 (dF = 16; 80)
  (20:5)                                                                                                                             

  P                                    0.0002   0.0001   0.0001                                                                      

  Docosapentaenoic acid\               125; 5   F        26.25 (dF = 4; 20)                                    30.06 (dF = 4; 80)    3.40 (dF = 16; 80)
  (22:5)                                                                                                                             

  P                                    0.0001   0.0001   0.0002                                                                      
  ---------------------------------------------------------------------------------------------------------------------------------------------------------

Changes in egg yolk total fatty acid composition {#sec014}
------------------------------------------------

The dose-dependent effects of the diet supplied over the time of sampling on egg yolk FA concentration are shown in Figs [3](#pone.0216623.g003){ref-type="fig"}--[6](#pone.0216623.g006){ref-type="fig"}. Significant effects ([Table 1](#pone.0216623.t001){ref-type="table"}) of the diet supplied, time of sampling and their interaction was found for SFA and PUFA. As expected, post-hoc analysis showed that control (BASAL and VEHICLE) females maintained constant SFA and PUFA values throughout experimental manipulation ([Fig 3A--3C](#pone.0216623.g003){ref-type="fig"}). On the contrary, along the S period THY4 and THY6 induced PUFA increments that remained enhanced even at 21 days of pS, while THY2 failed to increase PUFA ([Fig 3C](#pone.0216623.g003){ref-type="fig"}). Specifically, all THY supplemented diets increased 22:6 and 20:5 from 7 days of S on, but only THY4 and THY6 showed higher concentrations of 18:3 and 20:4, from 14 days of S onwards ([Fig 6B--6E](#pone.0216623.g006){ref-type="fig"}). In addition, THY2 and THY4 required 14 days of S for increasing 22:5, while THY6 needed only 7 days of S for achieving similar changes ([Fig 6F](#pone.0216623.g006){ref-type="fig"}). On the other hand, THY2 required 28 days of S to reduce the SFA concentration, while THY4 and THY6 only needed 14 days of S for a reduction of similar and even greater magnitude, respectively. However, after 21 days of pS the aforementioned effect disappeared in THY2 but not in THY4 and THY6 ([Fig 3A](#pone.0216623.g003){ref-type="fig"}). Concomitantly, reduced 16:0 and 18:0 concentrations were achieved by 14 days of S in THY4 and THY6 and by 28 days of S in THY2. After 21 days of pS those effects continued in all diets, except for the 16:0 and 18:0 concentrations in THY2 and THY6, respectively, that returned to initial levels ([Fig 4A and 4B](#pone.0216623.g004){ref-type="fig"}). No differences were observed between the diet supplied, time of sampling or their interaction in MUFA ([Fig 3B](#pone.0216623.g003){ref-type="fig"}). However, a transient decrease of 16:1 was observed by 7 and 14 days of S in THY2 ([Fig 5A and 5B](#pone.0216623.g005){ref-type="fig"}) and at 21 days of pS in THY4 and THY6 respect to their diet and time counterparts.

![Concentration of saturated, monounsaturated and polyunsaturated fatty acids of quail egg yolk.\
Mean ± SEM of content (g/100 g FAME) of (A) saturated (myristic + pentadecanoic + palmitic + stearic acids), (B) monounsaturated (palmitoleic + oleic acids) and (C) polyunsaturated (linoleic + linolenic + arachidonic + docosahexaenoic + eicosapentaenoic + docosapentaenoic acids) fatty acids of quail egg yolk laid by females fed on the control diets (BASAL and VEHICLE) or supplemented with 2, 4, and 6.25 g of thymol/kg of feed (THY2, THY4 and THY6, respectively) at 0, 7, 14, and 28 days of the supplementation period (S) and after 21 days of supplement withdrawal (pS). Arrow pointing down indicates the end of the S period. Brackets refer to measurements within a time of sampling. Different letters (a, b, c, d) indicate statistical differences. The same 25 females (5 per diet supplied) were analyzed on each of the five sample points (125 eggs total).](pone.0216623.g003){#pone.0216623.g003}

![Concentration of saturated fatty acids of quail egg yolk.\
Mean ± SEM of content (g/100 g FAME) of (A) palmitic (16:0) and (B) stearic acids (18:0) of quail egg yolk laid by females fed on the control diets (BASAL and VEHICLE) or supplemented with 2, 4, and 6.25 g of thymol/kg of feed (THY2, THY4 and THY6, respectively) at 0, 7, 14, and 28 days of the supplementation period (S) and after 21 days of supplement withdrawal (pS). Arrow pointing down indicates the end of the S period. Different letters (a, b, c) indicate statistical differences. Brackets refer to measurements within a time of sampling. The same 25 females (5 per diet supplied) were analyzed on each of the five sample points (125 eggs total).](pone.0216623.g004){#pone.0216623.g004}

![Concentration of monounsaturated fatty acids of quail egg yolk.\
Mean ± SEM of content (g/100 g FAME) of (A) palmitoleic (16:1) and (B) oleic acids (18:1) of quail egg yolk laid by females fed on the control diets (BASAL and VEHICLE) or supplemented with 2, 4, and 6.25 g of thymol/kg of feed (THY2, THY4 and THY6, respectively) at 0, 7, 14, and 28 days of the supplementation period (S) and after 21 days of supplement withdrawal (pS). Arrow pointing down indicates the end of the S period. Different letters (a, b) indicate statistical differences. Brackets refer to measurements within a time of sampling. The same 25 females (5 per diet supplied) were analyzed on each of the five sample points (125 eggs total).](pone.0216623.g005){#pone.0216623.g005}

![Concentration polyunsaturated fatty acids of quail egg yolk.\
Mean ± SEM of content (g/100 g FAME) of (A) linoleic (18:2), (B) linolenic (18:3), (C) arachidonic (20:4), (D) docosahexaenoic (22:6), (E) eicosapentaenoic (20:5) and (F) docosapentaenoic (22:5) acids of quail egg yolk laid by females fed on the control diets (BASAL and VEHICLE) or supplemented with 2, 4, and 6.25 g of thymol/kg of feed (THY2, THY4 and THY6, respectively) at 0, 7, 14, and 28 days of the supplementation period (S) and after 21 days of supplement withdrawal (pS). Arrow pointing down indicates the end of the S period. Different letters (a, b) indicate statistical differences. Brackets refer to measurements within a time of sampling. The same 25 females (5 per diet supplied) were analyzed on each of the five sample points (125 eggs total).](pone.0216623.g006){#pone.0216623.g006}

Female performance traits {#sec015}
-------------------------

The effects of the diet supplied over the time of sampling on variables related to performance (body weight, feed intake, egg laying, morphometric characteristics and constituents of eggs) are shown in [Table 2](#pone.0216623.t002){ref-type="table"}. Because no effects of the diet supplied, time of sampling or interaction were found, the Table is only showing the overall averages. Considering that no differences in the daily feed intake was observed between treatments (30.3 ± 1 g/day/animal), it can be assumed that the amount of THY consumed was proportional to the dose supplemented. By measures of THY concentration in the feed ([S4](#pone.0216623.s004){ref-type="supplementary-material"} and [S5](#pone.0216623.s005){ref-type="supplementary-material"} Tables) we were able to estimate a daily THY intake of 0.26, 0.70 and 1.2 mg/day/animal for THY2, THY4 and THY6, respectively. Thus, concentrations of THY transferred to the egg yolk and droppings during the plateau respectively correspond to \~0.13--0.25% and \~1.57--3.47% of the amount THY ingested.

Regarding general welfare, 100% of the birds of all treatments showed optimal plumage on the back and rump and around the cloacae, no skin lesions were observed, and only minimal proliferation of epithelium were observed (category 0) throughout S and pS periods. In relation to plumage of the neck and head, eye pathologies and dirt in the cloacae and legs, only a few isolated cases of category 1 were observed and were not associated with any particular treatment.

10.1371/journal.pone.0216623.t002

###### Overall mean values (± SEM) and statistical information regarding performance related variables from female quail fed with control diets or supplemented with thymol (Diet supplied) over five time points (Time of sampling).

![](pone.0216623.t002){#pone.0216623.t002g}

  Variables                                                   Mean ± SEM   *p*-Value                       
  ----------------------------------------------------------- ------------ ----------- ----- ------ ------ ------
  Weekly Body Weight per individual (g)                       254          ±           1     0.83   0.17   0.92
  Weekly Feed Intake per individual (g)                       212          ±           2     0.55   0.11   0.88
  Cumulative number of eggs                                   42           ±           1     0.39   \-     \-
  Egg weight (g)                                              11.3         ±           0.1   0.50   0.49   0.26
  Egg shell (%)                                               14.4         ±           0.2   0.83   0.54   0.71
  Egg yolk (%)                                                37.0         ±           0.4   0.90   0.87   0.99
  Egg albumen (%)                                             48.6         ±           0.5   0.95   0.96   0.99
  Egg shape index (%) [\*](#t002fn002){ref-type="table-fn"}   79.5         ±           0.3   0.73   0.46   0.77

Considering that no effects of the diet supplied, time of sampling or their interaction were found, only overall means are shown. Two control (BASAL and VEHICLE) and three supplemented diets (2, 4, and 6.25 g of thymol/kg of feed) were used. The five sampling time points used were at 0, 7, 14, and 28 days of the supplementation period and after 21 days of supplement withdrawal.

\* Egg shape index = (egg width / egg length) x 100

Liver histological analysis {#sec016}
---------------------------

As a general description of the state of experimental animals, representative photomicrographs and the frequency of histopathological alterations registered in all livers analyzed regardless of the diet supplied or sample point are presented in Figs [7](#pone.0216623.g007){ref-type="fig"} and [8](#pone.0216623.g008){ref-type="fig"}, respectively. The presence of steatosis or fatty degeneration was recorded in 89% of the livers evaluated (Figs [7B](#pone.0216623.g007){ref-type="fig"} and [8](#pone.0216623.g008){ref-type="fig"}). Sinusoidal dilatation and vascular congestion (both considered reversible changes) were observed respectively in 35% and 26% of the samples (Figs [7C](#pone.0216623.g007){ref-type="fig"} and [8](#pone.0216623.g008){ref-type="fig"}). A low number of small necrotic foci (12%) and foci of oval cells (associated with tissue regeneration) were found (Figs [7D](#pone.0216623.g007){ref-type="fig"} and [8](#pone.0216623.g008){ref-type="fig"}). Both the leukocyte infiltration and the pyknotic nuclei were recorded at low frequency (\<5%). Thus, among histopathological alterations, regressive changes (PR2: steatosis or fatty degeneration and necrosis) registered the highest frequency, followed by circulatory alterations (PR1: sinusoidal dilatation and vascular congestion) and finally progressive and inflammatory changes (PR3: foci of oval cells and PR4: inflammation) ([Fig 8](#pone.0216623.g008){ref-type="fig"}).

![Example photomicrographs of quail liver 40X.\
(A) Normal liver, (B) liver with steatosis or fatty degeneration, (C) vascular congestion and dilatation of sinusoids, and (D) oval cell focus. Arrows point to representative examples of the corresponding alteration in the photograph.](pone.0216623.g007){#pone.0216623.g007}

![Frequency of histopathological alterations registered in all livers analyzed.\
The reaction pattern (RP) to which the alterations correspond is indicated with different intensity of gray and a circular label: RP1 (circulatory disturbances), RP2 (regressive changes), RP3 (progressive changes), RP4 (inflammation) (n = 5; N = 45, only 5 birds from the basal diet were studied).](pone.0216623.g008){#pone.0216623.g008}

The effects of dietary supplementation on liver histopathological indices of animals that had gone through 28 days of S and the pS period are shown in [Table 3](#pone.0216623.t003){ref-type="table"}. Because no treatment effects were found, only overall averages are shown. Moreover, as histopathological alterations corresponding to Rp3 and Rp4 were observed only in a few individuals that were not associated with any particular treatment, *p*-values in those cases were not calculated. Total histopathological indices varied between 17.6 and 27.6.

10.1371/journal.pone.0216623.t003

###### Overall mean values (± SEM) and statistical information regarding liver histopathological indices by reaction pattern and total liver index for female quail fed with control diets or supplemented with thymol (Diet supplied) slaughtered at two time points (Slaughter batch).

![](pone.0216623.t003){#pone.0216623.t003g}

  Index         Mean ± SEM   *p*-Value                        
  ------------- ------------ ----------- ------ ------ ------ ------
  HI~Liv.Rp1~   4,71         ±           0,41   0.37   0.74   0.67
  HI~Liv.Rp2~   16,80        ±           0,65   0.19   0.57   0.81
  HI~Liv.Rp3~   0,80         ±           0,24   \-     \-     \-
  HI~Liv.Rp4~   0,27         ±           0,27   \-     \-     \-
  HI~Liv~       22,58        ±           0,90   0.15   0.37   0.78

Considering that no effects of the diet supplied, slaughter batch or their interaction were found, only overall means are shown. Two control (BASAL and VEHICLE) and three supplemented diets (2, 4, and 6.25 g of thymol/kg of feed). Two slaughter batches were assessed, the first, once finished the supplementation period, and a second after the post-supplementation period of 21 days. HI = Histopathological index. Liv = Liver. RP = Reaction Pattern; RP1 (circulatory disturbances), RP2 (regressive changes), RP3 (progressive changes), RP4 (inflammation). The reaction pattern to which the indices correspond is indicated with different grey intensity (n = 5; N = 45, only 5 birds from the basal diet were studied).

Discussion {#sec017}
==========

The main contribution of the present work is to show that both the dose of THY and the duration of the S period directly modulate the FA concentrations in quail eggs showing positive changes that remain apparent even after 21 days of THY withdrawal. Interestingly, the phenomenon was observed without changes in liver histology or impairments in any of the female productive traits registered. Furthermore, the bioavailability of THY both in the egg yolk and in droppings (i.e. an indicator of changes in circulating levels of THY) was also directly related to the concentration of THY and the duration of the supplementation.

In general, THY supplementation induced increments in PUFA concentration with a decrement in SFA in the egg yolk that were evident after 14 days of supplementation. These changes in the FA profile are consistent with an improved nutritional quality of eggs both from human nutrition standpoint (i.e. for consumption of healthy eggs; \[[@pone.0216623.ref017],[@pone.0216623.ref018]\]) and for early avian nutrition and hatching success \[[@pone.0216623.ref015],[@pone.0216623.ref016],[@pone.0216623.ref020]\].

By simultaneously assessing the dynamics of changes in THY and FA concentration along S and pS periods in several doses of THY, we were able to display the relations between the pattern of change in each variable (time-dose response curves) that may account for the multiple possible roles of THY in vivo. In the initial phase of the S period, both THY and PUFA concentrations increased over time. Afterwards, in a second phase, although THY concentration plateaued both in the egg yolk and droppings, PUFA concentration in the yolk continued increasing. Likewise, after THY supplementation withdrawal (pS period), while THY concentration was already depleted, PUFA concentration remain increased. An inverse relation of patterns was observed for SFA. Thus, these results provide evidence towards the hypothesis that THY modulation of FA profile is beyond its direct antioxidant activity (i.e. scavenging free radicals or chelating metal ions; \[[@pone.0216623.ref053]--[@pone.0216623.ref056]\]). The further FA-modulation evidenced in the second phase and during pS can be understood under different rational. First, FA-modulation can be considered a result of the sum of effects of the direct and indirect THY antioxidant activity \[[@pone.0216623.ref008],[@pone.0216623.ref013],[@pone.0216623.ref057]--[@pone.0216623.ref059]\] in different organs \[[@pone.0216623.ref009],[@pone.0216623.ref060]--[@pone.0216623.ref062]\]. Second, THY properties could affect other metabolic pathways that could conduce to PUFA increments \[[@pone.0216623.ref013],[@pone.0216623.ref063]--[@pone.0216623.ref066]\]. Third, FA-modulation mediated by the PUFA \[[@pone.0216623.ref067],[@pone.0216623.ref068]\], specifically, in the pS period. In the following paragraphs these three alternatives are explained in detailed.

In regard to the potential direct antioxidant effect of THY in target tissues (i.e. yolk) it is important to take into consideration the minimum concentration necessary to provide meaningful effects. In our study the highest concentrations of THY detected was in the range of 406 ng/g of egg yolk similar to other studies \[[@pone.0216623.ref034],[@pone.0216623.ref038]\], which is equivalent to \~3.05 uM. It has been stated that given a total antioxidant value in human plasma of over 103 mM, a minimum concentration of 20--50 mM (\~36%) of an additional antioxidant from dietary sources would be required to make a significant contribution to systemic antioxidant capacity \[[@pone.0216623.ref069]\]. A similar situation would be found in chickens where antioxidant concentrations in plasma such as vitamin C and vitamin E would be in a range of 61--66 uM and 13--15 uM, respectively, and total antioxidant value in plasma could vary from 336.9 mM up to 740--830 mM, considering that dietary polyphenols result in unconjugated serum levels of up to 1 mM \[[@pone.0216623.ref070]\]. In the same way, it has been demonstrated that a concentration of 278 ug of THY/g of yolk was needed to be added to a control yolk to display an antioxidant activity equivalent to that of a yolk from a thyme treated hen \[[@pone.0216623.ref014]\]. Although these authors attributed the increased antioxidant status and FA modulation observed in vivo to the activity of the other components in thyme, their result also could be associated with THY involvement in other mechanisms than the direct antioxidant activity in the body. It is important to mention that these authors were not able to analyze the actual concentration of THY in eggs since at that moment they lacked a method to do so. It has been proposed that if polyphenols have direct antioxidant effects *in vivo*, they might be capable of exerting such effects more likely within the gastrointestinal tract, where high concentration of polyphenols may come into direct contact with cells without having undergone absorption and metabolism \[[@pone.0216623.ref060]\]. In this context, dietary grape seed proanthocyanidins in rats \[[@pone.0216623.ref061]\] and piglets \[[@pone.0216623.ref062]\] has been shown to suppress oxidative stress in the intestinal mucosa, improving general health status. This hypothesis would also be in accordance with the contention that the chain reaction included in the oxidation of consumed lipids could be inhibited by the transfer of natural antioxidants such as THY into the female body by feeding, consequently decreasing the oxidation of constituents transferred into the egg yolk and helping to maintain PUFA \[[@pone.0216623.ref071]\]. Thus, THY direct antioxidant activity at gastrointestinal tract level would be plausible, helping to promote the FA-modulation observed herein. However, the relatively low concentration of THY detected in target tissues seems to shift the rational from a focus on direct antioxidant properties to a focus on indirect antioxidant properties, biotransformation, signaling transduction and gene expression regulation.

The indirect antioxidant effects of THY are based on the potential pro-oxidant activity of this phenol. In several *in vitro* experimental systems THY has demonstrated to enhance reactive oxygen species (ROS) formation, in a dose and time dependent manner \[[@pone.0216623.ref072]--[@pone.0216623.ref074]\]. In this regard, recent studies have shown that administration of moderate doses of epigallocatechin gallate (EGCG) to mice can produce ROS, which activates the nuclear factor Nrf-2-mediated induction of antioxidant and other cytoprotective enzymes \[[@pone.0216623.ref075]--[@pone.0216623.ref077]\]. Analogous results have been reported in quail supplemented with EGCG \[[@pone.0216623.ref078]\]. Whether THY can exert a similar mechanism in vivo must be proved, but it would be consistent with its known effects on antioxidant enzymes activity in tissues with high PUFA absolute content (serum, liver, thigh muscle, brain). For example, in broiler \[[@pone.0216623.ref013]\] and rats \[[@pone.0216623.ref079]\], it has been demonstrated that dietary THY boosted glutathione peroxidase and superoxide dismutase activities along with a decrease in malondialdehyde levels and an increase in PUFA concentrations, as observed herein. Similar results have been found in chickens that were fed *Cinnamomum cassia* \[[@pone.0216623.ref080]\]. Thus, depending on the scale, pro-oxidant effects can be beneficial and induce FA profile changes.

Other metabolic pathways could also be affected by THY supplementation such as lipids digestion and fatty acids bioconversion. As it is widely known, birds, like other animals, can only acquire PUFA precursors (linoleic and alpha-linolenic acids) through the diet, since they are unable to synthesize them *de novo* \[[@pone.0216623.ref081]\]. Once these precursors are in the animal body, their long chain derivatives (LCPUFA) can be synthesized. Since the supplemented diets were equal in composition ([S3 Table](#pone.0216623.s003){ref-type="supplementary-material"}), it could be conceived that THY promotes greater bioavailability of PUFA precursors through increasing digestive enzyme activities and feed efficiency, which has been shown to be a dose-dependent phenomena \[[@pone.0216623.ref002],[@pone.0216623.ref013],[@pone.0216623.ref082]\]. In addition, THY could promote greater bioconversion of these precursors in their LCPUFA through increasing delta-desaturases enzymes activity in the liver. On this subject, it has been demonstrated that hydroxytyrosol (a natural polyphenol) supplementation in mice enhances liver delta-desaturases, associated not only with an improvement in n-3 PUFA concentrations but also with a decrease in oxidative stress biomarkers \[[@pone.0216623.ref066]\]. Both mechanisms proposed are consistent with our results where only the two highest doses of THY were able to increase alpha-linolenic acid concentration, from 14 days of S on, while the three doses induced changes in all long chain-PUFA (LCPUFA), which began to be observed at 7 days of S.

In relation to the third hypothesis mentioned above, it is important to note that PUFA regulatory functions have gathered much interest recently \[[@pone.0216623.ref067],[@pone.0216623.ref083]--[@pone.0216623.ref087]\]. Of great significance to us are the findings showing that docosahexaenoic and eicopentaenoic acids reduce ROS generation and increase glutathione, glutamate--cysteine ligase and glutathione peroxidase 4 levels in astrocytes in a dose-dependent manner (under basal condition and in H~2~O~2~-treated) \[[@pone.0216623.ref068]\]. Additionally, both n-3 PUFA activated transcription factor Nrf2 also in a dose-dependent manner. Thus, THY could initially promote increased circulating levels of PUFA but thereafter also PUFA could be contributing to generate an improved antioxidant status preventing its own peroxidation. This would explain the changes in FA that continue to occur even when there is no change in the circulating THY concentration or in the pS period, when the supply of this compound has been withdrawn. It would be of great importance to investigate the feasibility of this mechanism after THY supplementation in vivo, since the transcription factor Nrf2 could become a therapeutic target with beneficial effects in animal physiology \[[@pone.0216623.ref088]\].

In our study, since females were fully grown adults in their egg-laying peak, it was expected that performance traits remained optimal in all treatments \[[@pone.0216623.ref045],[@pone.0216623.ref046],[@pone.0216623.ref089],[@pone.0216623.ref090]\]. Other previous studies have reported that mixtures with THY had positive effects on growth performance, egg production and egg physical characteristics depending on the dose \[[@pone.0216623.ref004],[@pone.0216623.ref013],[@pone.0216623.ref091]\], which could be due to differences in the experimental protocols used, especially regarding the age of the animals evaluated. Moreover, it has also been suggested that the effects of THY may be greatly dependent on the diet formulation (affecting digestibility of nutritional components and EOs) and the environment (challenging conditions such as the firsts weeks of growing, heat stress, etc.) thus, under optimal conditions, no further performance enhancement could be evidenced \[[@pone.0216623.ref092],[@pone.0216623.ref093]\]. Also, we considered positive that THY supplementation did not affect physical egg traits nor the general well-being and histopathological features of the liver. In this regard, it is noteworthy to mention that steatosis or fatty degeneration observed in all livers is consistent with the reproductive status of the females (peak of laying) \[[@pone.0216623.ref094],[@pone.0216623.ref095]\]. We ruled out that it is due to overfeeding, given daily feed intakes were within the normal range for the species \[[@pone.0216623.ref045],[@pone.0216623.ref078]\] and that the composition of the feeds were in accordance with the recommendation for animals of this age and physiological state \[[@pone.0216623.ref042]\].

Conclusion {#sec018}
==========

This is the first study that using pure THY encompasses the in vivo effects of increasing concentrations of THY during and in the mid-term after chronic supplementation, the bioavailability of THY in the yolk and droppings, the total FA composition of the yolk and a series of indicators of productivity and general welfare status in adult quail. With this approach we showed dose and time dependent effects, that are consistent with THY direct and indirect antioxidant activities as well as its influence on other metabolic pathways. Thus, supplementation with THY4 and THY6 promotes the production of eggs with an improved nutritional quality, whose beneficial effects could be sustained for at least 21 days after a 28-day S period is finished. Thymol supplementation would be advisable for the production of healthier table eggs, and fertile eggs. Taken together with previous reports \[[@pone.0216623.ref015]\], it could also contribute to successful embryo development. Finally, the doses tested herein do not negatively affect productive performance traits nor liver histopathology.
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